“`html
Moderna Inc (MRNA) initiated trading of new options for the November 14th expiration today, featuring a notable put contract at the $25.00 strike price, currently bid at $1.52. Selling this put obligates investors to buy the stock at $25.00, effectively lowering the cost basis to $23.48, compared to the current trading price of $27.30, representing an 8% discount.
Additionally, a call contract at the $29.00 strike price, with a bid of $2.11, allows investors to commit to sell the stock if it reaches this price. This transaction could yield a total return of 13.96% if the stock is called away, while the odds of the call expiring worthless stand at 52%. Both contracts indicate implied volatility around 79%.
“`
